Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-8 of 8
Keywords: hepatocellular carcinoma (HCC)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Retraction: Targeting a LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma
Open Access
Journal:
Bioscience Reports
Biosci Rep (2024) 44 (8): BSR-2018-0896_RET.
Published: 28 August 2024
... © 2024 The Author(s). 2024 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . ENO1 Hepatocellular carcinoma (HCC) LncRNA P5848 Therapeutic target...
Articles
Journal:
Bioscience Reports
Biosci Rep (2020) 40 (8): BSR-20180896_EOC.
Published: 10 August 2020
... © 2020 The Author(s). 2020 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . ENO1 Hepatocellular carcinoma (HCC) LncRNA P5848 Therapeutic target...
Articles
Journal:
Bioscience Reports
Biosci Rep (2019) 39 (11): BSR20180896.
Published: 15 November 2019
...Xidan Zhu; Hui Yu; Baolin Li; Jing Quan; Zhangrui Zeng; Guangrong Li; Jinbo Liu Hepatocellular carcinoma (HCC) has a high recurrence rate and poor clinical outcome after currently used therapies, including radiofrequency ablation. To explore the possible mechanisms for the relapse of HCC...
Includes: Supplementary data
Articles
Journal:
Bioscience Reports
Biosci Rep (2018) 38 (6): BSR20180854.
Published: 09 November 2018
...Zheng-Yuan Xie; Mao-Sheng Liu; Cong Zhang; Peng-Cheng Cai; Zhi-Hua Xiao; Fen-Fen Wang Objective: To explore whether aspirin (ASA) enhances the sensitivity of hepatocellular carcinoma (HCC) side population (SP) cells to doxorubicin (Doxo) via miR-491/ATP-binding cassette sub-family G member 2 (ABCG2...
Articles
TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma
Open Access
Journal:
Bioscience Reports
Biosci Rep (2017) 37 (4): BSR20170301.
Published: 27 July 2017
... roles not fully elucidated in human malignancy. The current study aims to identify the clinical significance of TINCR in prognosis and malignant progression of hepatocellular carcinoma (HCC). TINCR expression in HCC specimens at various stages of tumorigenesis were measured by quantitative real-time RT...
Articles
Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma
Open Access
Journal:
Bioscience Reports
Biosci Rep (2016) 36 (3): e00335.
Published: 20 May 2016
...Guangsheng Yu; Jianlu Wang; Kesen Xu; Jiahong Dong Gemcitabine (GEM), a commonly used chemotherapeutic agent in hepatocellular carcinoma (HCC) patients, uses oxidative stress induction as a common effector pathway. However, GEM alone or in combination with oxaliplatin hardly renders any survival...
Articles
Journal:
Bioscience Reports
Biosci Rep (2015) 35 (4): e00231.
Published: 29 July 2015
...Guangsheng Yu; Jun Liu; Kesen Xu; Jiahong Dong Oxidative stress induction is a common effector pathway for commonly used chemotherapeutic agents like gemcitabine (GEM) in hepatocellular carcinoma (HCC) patients. However, GEM alone or in combination with oxiplatin hardly renders any survival...
Articles
Journal:
Bioscience Reports
Biosci Rep (2013) 33 (5): e00069.
Published: 17 September 2013
... (diaminobenzidine) peroxidase substrate (Dako) solution for colour development. cell proliferation GNAO1 hepatocellular carcinoma (HCC) senescence HCC (hepatocellular carcinoma) is one of the common malignant tumours around the world, and its global incidence rate has already exceeded 1 million per...
